Ginkgo Bioworks to Construct Autonomous Lab at Novo's U.S. R&D Site
Ginkgo Bioworks will construct an autonomous lab at Novo Nordisk's Waltham R&D site, marking a significant expansion in their partnership and showcasing the growing integration of robotics and AI in pharmaceutical research.